Explanation
Background: This legislation authorizes the establishment of a Universal Term Contract (UTC) with Public Health Service (PHS) Pharmaceuticals for prescription drugs. The Columbus Public Health Department is the sole user of this contract for pharmaceuticals. The contractor will provide FDA approved prescription drugs and any other products approved by the U.S. Department of Health and Human Services, at Public Health Service (PHS) cost. The PHS cost is Federal government discounted pricing as mandated in the 1992 Veterans Health Care Act, Section 602, 340B. The program requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices. The intent of the program is to allow covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.
The term of the proposed option contract is through April 30, 2020, with an option to extend for two (2) additional one (1) year periods, subject to mutual agreement by both parties. The Purchasing Office opened formal bids on March 9, 2017.
The Purchasing Office advertised and solicited competitive bids in accordance with relevant provisions of the City Code (RFQ004396). Twenty-one (21) bids were solicited; one (1) response was received.
The Purchasing Office is recommending award to the most responsive, responsible, and best bidder as follows:
Smith Medical Partners: CC# 261299438; Expires: 3/21/2019
Total Estimated Annual Expenditure: $250,000.00
This company is not debarred according to the Excluded Party Listing System of the Federal Government or prohibited from being awarded a contract according to the Auditor of State Unresolved Findings for Recovery Certified Search.
Fiscal Impact: Funding to establish this option contract is from the General Fund. City agencies will be required to obtain approval to expend from their own appropriations...
Click here for full text